Medical/Pharmaceuticals APAC News & Press Release Distribution

Tycoon Group Sustains Profitability: 2026 Interim Results Net Profit Surges 183% Year-on-Year

Business Demonstrates Strong Resilience, Profitability Continues to Materialise Results Highlights * Tycoon Group sustained its turnaround success from the previous year, recording a net profit of approximately HK$6.3 million during the Period (1H2025: net loss of approximately HK$7.7 millio...

2026-08-29 11:20 7490

INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces

ZIBO, China, Aug. 29, 2026 /PRNewswire/ -- INTCO Medical ("the Company", 300677.SZ), a leading global manufacturer of disposable gloves, reported revenue of RMB 6.91 billion (approx. US$1.03 billion) for the six months ended June 30, 2026, up 40.61% from a year ea...

2026-08-29 10:08 8112

Kazia Therapeutics Limited Announces Pricing of Up to $120 Million Public Offering

SYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced the ...

2026-08-28 19:30 3067

DualityBio Enters a Global Collaboration and License Agreement with Genentech to Develop Next-Generation ADCs Built on DualityBio's DUPAC Novel-Payload Platform

* Collaboration leverages DualityBio's proprietary DUPAC payload platform and early global clinical development capabilities, with Genentech assuming further clinical development and global commercialization * DUPAC, one of the DualityBio's four proprietary ADC technology platforms, comprises...

2026-08-28 12:20 2199

Singclean 2nd Leaders Summit Charts New Course in Global Aesthetics

SHANGHAI, Aug. 28, 2026 /PRNewswire/ -- Hosted within the IMCAS China Conference venue at W Shanghai - The Bund, Singclean 2nd International Medical Aesthetic Leaders Summit themed "Global Vision, Embark on a New Chapter" came to a successful conclusion. 2026 IMCAS China Singclean Highlight Vid...

2026-08-28 11:00 2484

NECA Expands Telehealth Care with New Counselling and Dietitian Support

NeuroEndocrine Cancer Australia strengthens free specialist support for patients, carers, and families affected by neuroendocrine cancer. SYDNEY, Aug. 28, 2026 /PRNewswire/ -- NeuroEndocrine Cancer Australia (NECA) has expanded its national telehealth service to include dedicated counselling and...

2026-08-28 07:00 2251

NECA Expands Telehealth Care with New Counselling and Dietitian Support

Kazia Therapeutics Limited Announces Proposed Public Offering

SYDNEY, Aug. 28, 2026 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA) ("Kazia" or the "Company"), an oncology-focused biotechnology company developing therapies that selectively reprogram cancer biology, restore anti-tumor immunity and overcome treatment resistance, today announced that...

2026-08-28 05:14 3654

Kazia Therapeutics Reports 100% Clinical Benefit Rate in Initial Six Patients Treated for Advanced Triple-Negative Breast Cancer

Durable Complete Metabolic Response Ongoing Since November 2025 All Evaluable Patients Demonstrated Reductions in Metastasis-Associated CTC Clusters and Terminally Exhausted T cells, With Median Reductions of 83% and 51% Respectively No Treatment-Related Serious Adverse Events Observed SYDNEY, ...

2026-08-28 04:01 4157

Global genomics and multi-omics leader Novogene to establish its first Australian laboratory at Cabrini Health, accelerating access to precision cancer care

MELBOURNE, Australia, Aug. 28, 2026 /PRNewswire/ -- Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced genomic capabilities closer to Australian patients and researchers, reducing the wait for genomic test results that can infor...

2026-08-28 04:00 4677

Global genomics and multi-omics leader Novogene to establish its first Australian laboratory at Cabrini Health, accelerating access to precision cancer care

ZEISS debuts DORC EVA NEXUS for cataract surgery at ESCRS

Now spanning ZEISS Retina and Cataract Workflows, the EVA NEXUS™ ophthalmic surgical system from ZEISS comes in a cataract-only configuration, bringing a tailored approach to different surgical needs. JENA, Germany, Aug. 27, 2026 /PRNewswire/ -- | Carl Zeiss Meditec AG

2026-08-27 21:03 1703

ZEISS debuts DORC EVA NEXUS for cataract surgery at ESCRS

Fosun International Reports 1H2026 Results: Total Revenue RMB86.96 Billion, Net Profit RMB1.72 Billion

Highlights: * Total revenue reached RMB86.96 billion, and profit attributable to owners of the parent reached RMB1.72 billion, representing a year-on-year increase of 160.3%; * Operational quality of core industries steadily improved, with industrial operation profit reaching RMB3.69 billion...

2026-08-27 19:27 3521

AsiaPay Partners with Generika Drugstore to Launch a Convenient and Secure Digital Payment Solution, Enhancing Customer Payment Experience in The Philippines

MANILA, Philippines, Aug. 27, 2026 /PRNewswire/ -- AsiaPay, a leading digital payment service provider and technology company in Asia, has partnered with Generika Drugstore, the country's premier generic pharma retail chain and part of AC Health, the healthcare arm of the Ayala Group, to signific...

2026-08-27 17:31 2905

Sunway Medical Centre Penang Receives Dual Honours at the Asia Pacific Enterprise Awards (APEA) 2026 Regional Edition for Healthcare Excellence and Brand Leadership

SINGAPORE, Aug. 27, 2026 /PRNewswire/ -- Sunway Medical Centre Penang (SMCP) has been honoured with the Corporate Excellence and Inspirational Brand awards at the Asia Pacific Enterprise Awards (APEA) 2026 Regional Edition by Enterprise Asia, recognising its strong growth trajectory as a leading ...

2026-08-27 16:27 3910

Countdown to BIOHK2026: World-Class Biotech Convention Prepares to Host Global Pavilions, Multi-Track Forums, and Signature Executive Networking

HONG KONG, Aug. 27, 2026 /PRNewswire/ -- As a premier global landmark in biotech, BIOHK2026 convenes international biotech hubs, cross-disciplinary industry forums, and high-impact networking events to accelerate cross-border partnerships in Hong Kong.

2026-08-27 12:06 3247

Countdown to BIOHK2026: World-Class Biotech Convention Prepares to Host Global Pavilions, Multi-Track Forums, and Signature Executive Networking

Exascend Deploys Advanced Medical-Grade Storage Solutions to Power Next-Generation Healthcare Systems

TAIPEI, Aug. 27, 2026 /PRNewswire/ -- Exascend announced the successful deployment of its Medical-Grade Storage Solutions in collaboration with a leading healthcare technology provider, supporting the demanding requirements of next-generation medical systems. The enterprise-grade solution deliver...

2026-08-27 11:00 2315

Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

BUENOS AIRES, Argentina, Aug. 27, 2026 /PRNewswire/ -- Biosidus, an Argentine biotechnology company with more than four decades of experience in the development and manufacturing of biosimilar medicines, announced that its new bioreactor plant is now operational, increasing the company's biologic...

2026-08-27 05:00 2353

Biosidus expands biologics manufacturing capacity and strengthens global supply capabilities for agalsidase beta

DarwinHealth Introduces Quantum Cancer Biology: A Cell-State Systems Biology Framework for Precision Oncology

New paradigm integrates single-cell transcriptomics, regulatory network inference, and AI to decode—and therapeutically target—the multiple, co-existing cancer cell states that drive resistance in pancreatic cancer, glioblastoma, and other lethal malignancies NEW YORK, Aug. 26, 2026 /PRNewswire/...

2026-08-26 20:38 2604

Alebund Pharmaceuticals Announces 2026 Interim Results

SHANGHAI, Aug. 26, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; stock code: 09637.HK), a renal-focused biopharmaceutical company, today announced its unaudited consolidated interim results for the six months ended June 30, 2026 (the "Reporting Period...

2026-08-26 18:59 3031

HaemaLogiX Announces Major Milestone with First Patient Successfully Dosed with KMCAR™ T-Cell

KEY POINTS * First patient safely dosed in Phase 1 KOALA trial evaluating KMCAR™ T-cell therapy in patients with relapsed/refractory kappa-restricted multiple myeloma * Patient was monitored after initial dose to assess response and side-effects, with the treatment seen as well tolerated, an...

2026-08-26 08:00 1177

Metabolon Completes Landmark Global Health Pilot Advancing Women's and Infant Health

Innovative sample collection methods developed through Gates Foundation-funded grant enable high-quality metabolomics biomarker discovery in populations from low- and middle-income countries MORRISVILLE, N.C., Aug. 25, 2026 /PRNewswire/ -- Metabolon, Inc., the global leader in metabolomics solut...

2026-08-25 21:00 1009